Biosciences and Pharmaceuticals
The biosciences and pharmaceuticals sectors are growing significantly. This reflects the advances in medical knowledge and technology, as well as the depth and talent of world-class biomedical research, innovation and commercialisation in Australia and New Zealand. While strongly supported by the community and government, these sectors are subject to extensive regulatory compliance, competitive pressures and commercial risk.
DLA Phillips Fox helps minimise this risk through proactive advice on issues ranging from initial research and discovery to product commercialisation. We have substantial experience acting for government, research institutes, universities, spin-off companies and biotechnology and pharmaceutical companies in respect of the commercialisation of health care and therapeutic products.
We deliver:
- Comprehensive advice – we can help you manage all the issues, from policy and strategic advice to funding clinical trials, medical research, technology licensing and labelling requests.
- Broad experience – our lawyers have a diversity of backgrounds that span molecular biosciences, pharmacology and medicine, as well as commercial negotiations and business.
- Global insight – we can offer you international expertise drawn from our global alliance with DLA Piper. They represent a large number of leading US pharmaceutical and biotechnology companies.
We advise on:
- Negotiating terms sheets, research and licence agreements.
- Core conditions and warranties.
- Commercialising technology, methodology for royalty payments and key performance indicators.
- Cross-border licensing.
- Strategic alliances and partnering agreements.
- How to mitigate the risk of loss or misappropriation of critical scientific data.
- Milestones to related payments.
- How to strategically position your business to take advantage of a rapidly changing global regulatory environment.
- How to ensure intellectual property rights are protected through sub-contracts and sub- licences.
- Patent protection and enforcement in Australia and overseas.